Back to dashboard
Low impact

Tildrakizumab-asmn (Ilumya) (CPB 1012, reviewed 2026-07-01)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 18, 2026
Days to comply
—

Related policy hubs